EGFR and breast cancer: ERα negative breast cancer cells proliferate independently of oestrogen signalling through other signalling pathways such as the EGFR, and downstream PI3K/Akt/mTOR, NF-κB signalling pathways (Saxena and Dwivedi 2012).